Patient Characteristics
| UPN . | Family . | CNS . | HLH Stage . | Age at . | Sex . | Donor . | Engrafted . | Days to . | Maximum . | Maximum . | HLH Stage . | Status/Autopsy . | Survival . | Cause of Death . | Karnofsky . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | History . | Disease . | at BMT . | BMT (yr) . | . | Match . | . | ANC >500 . | aGVHD . | cGVHD . | Post-BMT . | (Y/N) . | (d) . | . | Score . |
| . | . | at DX . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| 9905 | − | + | Quiescent | 0.4 | M | MSD 6/6 | + | 16 | 0 | 0 | NED | Died/(N) | 41 | Aspiration pneumonia | − |
| ø972 | − | + | Active | 0.6 | M | MSD 6/6 | + | 25 | 0 | 0 | NED | Died/(Y) | 43 | MOF | − |
| 1925 | − | − | Quiescent | 4 | M | MSD 6/6 | + | 29 | 0 | 0 | NED | Alive* | 1,029 | — | 100% |
| 2153 | + | + | Quiescent | 0.7 | M | MSD 6/6 | + | 19 | 0 | 0 | NED | Alive | 645 | — | 100% |
| 9901 | − | + | Active | 0.8 | M | URD 6/6 | + | 40 | 0 | 0 | Progressive | Died/(N) | 99 | Progressive HLH | — |
| 9902 | + | + | Quiescent | 1.5 | M | URD 6/6 | + | 25 | 0 | 0 | NED | Alive | 1,337 | — | 90% |
| 9904 | − | + | Quiescent | 3 | M | URD 6/6 | + | 19 | III | Extensive | NED | Alive | 1,116 | — | 60% |
| 1187 | − | + | Active | 0.6 | F | URD 5/6 | NE | NE | 0 | 0 | Progressive | Died/(Y) | 1 | Aspergillosis | — |
| 1221 | + | + | Active | 0.6 | F | URD 6/6 | NE | NE | 0 | 0 | Progressive | Died/(Y) | 180 | Progressive HLH | — |
| 1527 | − | + | Quiescent | 0.65 | F | URD 6/6 | + | 34 | II | Extensive | NED | Died/(N) | 463 | Sepsis | — |
| 1541 | − | − | Quiescent | 0.9 | F | URD 5/6 | + | 25 | II | 0 | NED | Died/(Y) | 46 | Hemorrhage | — |
| 1602 | − | − | Quiescent | 0.5 | M | URD 6/6 | + | 24 | I | 0 | NED | Died/(N) | 39 | ARDS | — |
| 1660 | + | − | Quiescent | 0.7 | M | URD 6/6 | + | 24 | 0 | Extensive | NED | Alive | 1,532 | — | 100% |
| 1769 | − | − | Quiescent | 0.6 | F | URD 5/6 | + | 16 | 0 | Extensive | NED | Alive | 1,278 | — | 100% |
| 1884 | − | − | Active | 1.7 | F | URD 6/6 | + | 25 | II | Limited | NED | Alive | 1,112 | — | 100% |
| 2034 | − | + | Quiescent | 1.3 | M | URD 5/6 | + | 23 | II | 0 | NED | Died/(Y) | 134 | ARDS | — |
| 2056 | + | + | Quiescent | 3.7 | F | URD 5/6 | + | 21 | II | 0 | NED | Died/(N) | 86 | Fungal infection | — |
| 2177 | − | − | Quiescent | 1.9 | M | URD 5/6 | + | 50 | I | 0 | NED | Alive | 609 | — | 100% |
| 2186 | + | + | Active | 5.3 | M | URD 5/6 | + | 19 | III | 0 | NED | Died/(N) | 85 | MOF/GVHD | — |
| 2229 | − | + | Quiescent | 0.56 | M | URD 6/6 | + | 29 | III | 0 | NED | Alive | 503 | — | 100% |
| UPN . | Family . | CNS . | HLH Stage . | Age at . | Sex . | Donor . | Engrafted . | Days to . | Maximum . | Maximum . | HLH Stage . | Status/Autopsy . | Survival . | Cause of Death . | Karnofsky . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | History . | Disease . | at BMT . | BMT (yr) . | . | Match . | . | ANC >500 . | aGVHD . | cGVHD . | Post-BMT . | (Y/N) . | (d) . | . | Score . |
| . | . | at DX . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| 9905 | − | + | Quiescent | 0.4 | M | MSD 6/6 | + | 16 | 0 | 0 | NED | Died/(N) | 41 | Aspiration pneumonia | − |
| ø972 | − | + | Active | 0.6 | M | MSD 6/6 | + | 25 | 0 | 0 | NED | Died/(Y) | 43 | MOF | − |
| 1925 | − | − | Quiescent | 4 | M | MSD 6/6 | + | 29 | 0 | 0 | NED | Alive* | 1,029 | — | 100% |
| 2153 | + | + | Quiescent | 0.7 | M | MSD 6/6 | + | 19 | 0 | 0 | NED | Alive | 645 | — | 100% |
| 9901 | − | + | Active | 0.8 | M | URD 6/6 | + | 40 | 0 | 0 | Progressive | Died/(N) | 99 | Progressive HLH | — |
| 9902 | + | + | Quiescent | 1.5 | M | URD 6/6 | + | 25 | 0 | 0 | NED | Alive | 1,337 | — | 90% |
| 9904 | − | + | Quiescent | 3 | M | URD 6/6 | + | 19 | III | Extensive | NED | Alive | 1,116 | — | 60% |
| 1187 | − | + | Active | 0.6 | F | URD 5/6 | NE | NE | 0 | 0 | Progressive | Died/(Y) | 1 | Aspergillosis | — |
| 1221 | + | + | Active | 0.6 | F | URD 6/6 | NE | NE | 0 | 0 | Progressive | Died/(Y) | 180 | Progressive HLH | — |
| 1527 | − | + | Quiescent | 0.65 | F | URD 6/6 | + | 34 | II | Extensive | NED | Died/(N) | 463 | Sepsis | — |
| 1541 | − | − | Quiescent | 0.9 | F | URD 5/6 | + | 25 | II | 0 | NED | Died/(Y) | 46 | Hemorrhage | — |
| 1602 | − | − | Quiescent | 0.5 | M | URD 6/6 | + | 24 | I | 0 | NED | Died/(N) | 39 | ARDS | — |
| 1660 | + | − | Quiescent | 0.7 | M | URD 6/6 | + | 24 | 0 | Extensive | NED | Alive | 1,532 | — | 100% |
| 1769 | − | − | Quiescent | 0.6 | F | URD 5/6 | + | 16 | 0 | Extensive | NED | Alive | 1,278 | — | 100% |
| 1884 | − | − | Active | 1.7 | F | URD 6/6 | + | 25 | II | Limited | NED | Alive | 1,112 | — | 100% |
| 2034 | − | + | Quiescent | 1.3 | M | URD 5/6 | + | 23 | II | 0 | NED | Died/(Y) | 134 | ARDS | — |
| 2056 | + | + | Quiescent | 3.7 | F | URD 5/6 | + | 21 | II | 0 | NED | Died/(N) | 86 | Fungal infection | — |
| 2177 | − | − | Quiescent | 1.9 | M | URD 5/6 | + | 50 | I | 0 | NED | Alive | 609 | — | 100% |
| 2186 | + | + | Active | 5.3 | M | URD 5/6 | + | 19 | III | 0 | NED | Died/(N) | 85 | MOF/GVHD | — |
| 2229 | − | + | Quiescent | 0.56 | M | URD 6/6 | + | 29 | III | 0 | NED | Alive | 503 | — | 100% |
Abbreviations: ARDS, adult respiratory distress syndrome; cGVHD, chronic graft-versus-host disease; Dx, diagnosis; NE, not evaluable; NED, no evidence of disease; MOF, multiorgan failure.
Alive also indicates the patient to be free of HLH.